Correlation Between Dentsu and Allovir

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dentsu and Allovir at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dentsu and Allovir into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dentsu Inc and Allovir, you can compare the effects of market volatilities on Dentsu and Allovir and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dentsu with a short position of Allovir. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dentsu and Allovir.

Diversification Opportunities for Dentsu and Allovir

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between Dentsu and Allovir is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Dentsu Inc and Allovir in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allovir and Dentsu is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dentsu Inc are associated (or correlated) with Allovir. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allovir has no effect on the direction of Dentsu i.e., Dentsu and Allovir go up and down completely randomly.

Pair Corralation between Dentsu and Allovir

Assuming the 90 days horizon Dentsu Inc is expected to under-perform the Allovir. In addition to that, Dentsu is 8.99 times more volatile than Allovir. It trades about -0.23 of its total potential returns per unit of risk. Allovir is currently generating about -0.03 per unit of volatility. If you would invest  2,985  in Allovir on August 28, 2022 and sell it today you would lose (2,251)  from holding Allovir or give up 75.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.77%
ValuesDaily Returns

Dentsu Inc  vs.  Allovir

 Performance (%) 
       Timeline  
Dentsu Inc 
Dentsu Performance
0 of 100
Over the last 90 days Dentsu Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Dentsu Price Channel

Allovir 
Allovir Performance
2 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Allovir are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Allovir may actually be approaching a critical reversion point that can send shares even higher in December 2022.

Allovir Price Channel

Dentsu and Allovir Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dentsu and Allovir

The main advantage of trading using opposite Dentsu and Allovir positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dentsu position performs unexpectedly, Allovir can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will offset losses from the drop in Allovir's long position.
Dentsu vs. Omnicom Group
Dentsu vs. Interpublic Group
Dentsu vs. Canadian Natural Resources
The idea behind Dentsu Inc and Allovir pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Allovir vs. Regeneron Pharmaceuticals
Allovir vs. Vertex Pharmaceutic
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go